Lista de obras - Katherine Woods - Dominio Público Uruguay

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

scientific article published on 18 March 2020

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

artículo científico publicado en 2018

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

artículo científico publicado en 2020

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

artículo científico publicado en 2017

Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells

artículo científico publicado en 2014

Evolving role of tumor antigens for future melanoma therapies.

artículo científico publicado en 2014

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

artículo científico publicado en 2012

Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.

artículo científico publicado en 2011

Identification and characterization of a stage specific membrane protein involved in flagellar attachment in Trypanosoma brucei

artículo científico publicado en 2013

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

artículo científico publicado en 2014

Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules

article published in the Proceedings of the National Academy of Sciences of the United States of America

MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.

artículo científico publicado en 2014

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma.

artículo científico publicado en 2016

Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma

scientific article published on 16 September 2020

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

artículo científico publicado en 2018

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

artículo científico publicado en 2014

Tumor-specific T-cell help is associated with improved survival in melanoma.

artículo científico publicado en 2013

Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma

artículo científico publicado en 2015

Lista de obras de Katherine Woods

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells

Evolving role of tumor antigens for future melanoma therapies.

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.

Identification and characterization of a stage specific membrane protein involved in flagellar attachment in Trypanosoma brucei

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules

MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma.

Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

Tumor-specific T-cell help is associated with improved survival in melanoma.

Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma